State of the Science for MWCNT Release Measurement from Polymers: Progress of the NanoRelease Project

Richard Canady

Richard Canady

Director, Center for Risk Science Innovation and Application (RSIA)

ILSI Research Foundation

Dr. Canady is Director the Center for Risk Science Innovation and Application of the ILSI Research Foundation, which fosters collaborative research supporting risk management needs.  He is a leading expert in regulatory risk assessment having led multidisciplinary teams of policy and technical experts in the resolution of a wide range of cutting edge health risk management issues over a 20+ year teaching and public policy career.  The topics covered by Dr. Canady included genomics, nanotechnology, biotechnology, obesity, contaminants in the environment and in foods, and medical product development.  

Dr. Canady served as a senior policy advisor to the Office of the Commissioner of US FDA and the Office of Science and Technology Policy of the White House.  Extending his experience to the private sector, Dr. Canady has also served as a senior advisor for the law firm McKenna, Long & Aldridge in health risk assessment serving major industrial and pharmaceutical clients.

He has led and served on FDA and White House policy coordination groups on nanotechnology environmental health and safety, led OECD guidance development on testing of nanomaterials, led WHO/FAO expert groups in evaluation of food contaminants, developed and led numerous workshops, panels and peer reviews on topics ranging from nanomaterial toxicity assessment to nanotechnology standard reference materials, research needs, and nanomaterial characterization both in US and in EU.

While at OSTP and at FDA Dr. Canady led the US National Nanotechnology Initiative’s review of research needs for risk management of nanomaterials.  At FDA he led the development and conduct of 2 major public meetings on nanotechnology, evaluated and developed policy for regulatory needs for nanomaterials, and led the science team and writing of the 2007 FDA Nanotechnology Task Force report that captured and shaped FDA policy on nanotechnology.

He also actively participated in guiding the development of nanomedicine testing programs for the US National Cancer Institute’s Nanotechnology Characterization Laboratory as a member of the oversight board for the NCL.

Sponsor & Exhibitor Opportunities

 Exhibit and Showcase
 Become a Sponsor

Please contact: Denise Lee


Program Tracks

Fabrication & Characterization

Advanced Materials

Electronics & Microsystems

Medical & Biotech

Energy & Environment

Business & Partnering

 

2012 TechConnect Corporate Acceleration Partners:

AC-NET
Applied Materials
Austin_Energy
BASF
BayerMaterialScience
bp
ConstellationEnergy
DOW
Fraunhofer TechBridge
Hitachi
Honda
IBM
Kauffman Foundation
Kodak
Lam
Lockheed Martin
MWV
nationalgrid
NortheastUtilities
novaris
Panasonic
PPG
Samsung
schlumberger
Shell_GameChanger
siemens
SK Innovation
SouthernCalEdison
Toray

In Partnership with

NSTI


Sponsorship Opportunities: Contact Denise Lee

Free Subscription

E-mail:

pbh(); ?>